Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: Correlation with analgesia

Abstract

We have investigated the influence of physico-chemical parameters (chemical structure and lipophilicity), biochemical properties (catabolism, affinity for 3H-etorphine binding sites and 3H-(D-Ala) 2-Leu 5-enkephalin amide binding sites) and biological activity in isolated organs (guinea-pig ileum and mouse vas deferens) on the regulation of analgesia induced after intracerebroventricular injection of various enkephalin analogs. The selectivity of these metabolically stable analogs for μ- and δ-receptors, present in guinea-pig ileum and mouse vas deferens respectively, depends on the C-terminal amino acid and also on the nature of the second D-amino-acid. A strong correlation exists between activity in guinea-pig ileum and affinity for 3H-etorpine binding sites suggesting that these sites in rat brain have properties identical to those of μ-receptors characterized in guinea-pig ileum. Similarly, the affinity for 3H-(D-Ala) 2-Leu 5-enkephalin amide binding sites in mouse brain is correlated to the activity in mouse vas deferens and suggests that central δ-receptors are not different from peripheral δ-receptors. If we consider morphine-like drugs and enkephalin analogs containing the same C-terminal amino acid as the enkephalins, there is a good correlation between activity on μ-receptors (affinity for 3H-etorphine binding sites and activity in guinea-pig ileum) and the antinociceptive activity. These results support the hypothesis that μ-receptors are strongly involved in the analgesic effect. However, when proline is the C-terminal amino acid, the antinoceptive activity was enhanced without any concomitant increase in the affinity. This activity enhancement was the same for each analog and a similar correlation (identical to what was found with other opioid peptides and opiates) could still be established. The reason for such a potentiation of the activity remains to be elucidated.